Covalon Technologies (OTCMKTS:CVALF) Shares Down 1.3% – Here’s Why

Covalon Technologies Ltd. (OTCMKTS:CVALFGet Free Report) fell 1.3% during trading on Thursday . The stock traded as low as $1.54 and last traded at $1.54. 800 shares traded hands during trading, a decline of 85% from the average session volume of 5,312 shares. The stock had previously closed at $1.56.

Covalon Technologies Stock Up 0.3%

The business has a 50 day simple moving average of $1.45 and a two-hundred day simple moving average of $1.34. The firm has a market cap of $42.66 million, a PE ratio of 38.63 and a beta of 0.62.

Covalon Technologies (OTCMKTS:CVALFGet Free Report) last released its earnings results on Thursday, May 21st. The company reported $0.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.01 by $0.02. Covalon Technologies had a return on equity of 5.74% and a net margin of 5.05%.The business had revenue of $6.27 million for the quarter, compared to analyst estimates of $6.70 million.

About Covalon Technologies

(Get Free Report)

Covalon Technologies Ltd. (OTCMKTS:CVALF) is a Canadian medical device and life sciences company specializing in advanced wound care and infection prevention solutions. Based in Toronto, Ontario, Covalon leverages proprietary photochemical bonding technology to create antimicrobial and anti-adhesion polymer coatings for a range of medical devices and wound dressings. The company’s core focus is on reducing surgical site infections and improving healing outcomes through innovative biomaterials.

The company’s product portfolio comprises hydrogel-based wound dressings and polymer-coated medical device components.

Featured Stories

Receive News & Ratings for Covalon Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covalon Technologies and related companies with MarketBeat.com's FREE daily email newsletter.